VAXCARE LLC NPI 1316058217

NPI Details

VAXCARE LLC is a family medicine in Orlando, FL. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. VAXCARE LLC NPI is 1316058217. The provider is registered as an organization entity type.
The provider .

The provider's business location address is:

800 N MAGNOLIA AVE STE 700
ORLANDO, FL
ZIP 32803-264
Phone: (888) 829-8550
Fax: (855) 418-9149

The provider's authorized official is Brett Kenefick .
The authorized official title is President and has the following contact phone number (888) 829-8550.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Pneumococcal vaccine, 13-valent (HCPCS:90670)
• Influenza vaccine, quadrivalent derived from recombinant dna (HCPCS:90682)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Adm sarscov2 50 mcg/.5 mlbst (HCPCS:0094A)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use (HCPCS:90671)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose (HCPCS:0011A)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose (HCPCS:0012A)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose (HCPCS:0001A)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Adm sarscv2 30mcg trs-sucr 1 (HCPCS:0051A)
• Administration of vaccine (HCPCS:90471)
• Adm sarscv2 30mcg trs-sucr 3 (HCPCS:0053A)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Adm sarscv2 30mcg trs-sucr 2 (HCPCS:0052A)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, dna, spike protein, adenovirus type 26 (ad26) vector, preservative free, 5x1010 viral particles/0.5ml dosage, single dose (HCPCS:0031A)
• Administration of vaccine, each additional vaccine (HCPCS:90472)

The enumeration date for this NPI number is 8/31/2006 and was last updated on 10/16/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: